Literature DB >> 26432499

Clinical Weighting of Drug-Drug Interactions in Hospitalized Elderly.

Teresa Juárez-Cedillo1,2, Cynthia Martinez-Hernández1, Angel Hernández-Constantino1, Juan Carlos Garcia-Cruz3, Annia M Avalos-Mejia1, Luis A Sánchez-Hurtado4,5, Valentin Islas Perez2, Philip D Hansten6.   

Abstract

Adverse drug reactions impact on patient health, effectiveness of pharmacological therapy and increased health care costs. This investigation intended to detect the most critical drug-drug interactions in hospitalized elderly patients, weighting clinical risk. We conducted a cross-sectional study between January and April 2014; all patients 70 years or older, hospitalized for >24 hr and prescribed at least one medication were included in the study. Drug-drug interactions were estimated by combining Stockley's, Hansten and Tatro drug interactions. Drug-drug interactions were weighted using a risk-analysis method based on failure modes, effects and criticality analysis. We calculated a criticality index for each drug involved in the drug-drug interactions based on the severity of the interaction mechanism, the frequency the drug was involved in drug-drug interactions and the risk of drug-drug interactions in patients with impaired renal function. The average number of drugs consumed in the hospital was 6 ± 2.69, involving 160 active ingredients. The most frequent were as follows: Furosemide, followed by Enalapril. Of drug-drug interactions, 2% were classified as contraindicated, 14% advised against and 83% advised caution during the hospital stay. Thirty-four drug-drug interactions were assessed, of which 23 were pharmacodynamic drug-drug interactions and 12 were pharmacokinetic drug-drug interactions (1 was both). The clinical risk calculated for each drug-drug interaction included heparins + non-steroidal anti-inflammatory drugs (NSAIDs) or Digoxin + Calcium Gluconate, cases which are pharmacodynamic drug-drug interactions with agonist effect and clinical risk of bleeding, one of the most common clinical risks in the hospital. An index of clinical risk for drug-drug interactions can be calculated based on severity by the interaction mechanism, the frequency that the drug is involved in drug-drug interactions and the risk of drug-drug interactions in an elderly patient with impaired renal function.
© 2015 Nordic Association for the Publication of BCPT (former Nordic Pharmacological Society).

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26432499     DOI: 10.1111/bcpt.12495

Source DB:  PubMed          Journal:  Basic Clin Pharmacol Toxicol        ISSN: 1742-7835            Impact factor:   4.080


  3 in total

1.  High-priority drug-drug interaction clinical decision support overrides in a newly implemented commercial computerized provider order-entry system: Override appropriateness and adverse drug events.

Authors:  Heba Edrees; Mary G Amato; Adrian Wong; Diane L Seger; David W Bates
Journal:  J Am Med Inform Assoc       Date:  2020-06-01       Impact factor: 4.497

2.  Drug-Related Problems in Hospitalised Patients with Chronic Kidney Disease: A Systematic Review.

Authors:  Wadia S Alruqayb; Malcolm J Price; Vibhu Paudyal; Anthony R Cox
Journal:  Drug Saf       Date:  2021-09-12       Impact factor: 5.606

Review 3.  Prevalence of drug interactions in hospitalised elderly patients: a systematic review.

Authors:  Luciana Mello de Oliveira; Juliana do Amaral Carneiro Diel; Alessandra Nunes; Tatiane da Silva Dal Pizzol
Journal:  Eur J Hosp Pharm       Date:  2020-02-10
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.